Fig. 1From: RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trialRLS-0071 Pharmacokinetics. A Mean RLS-0071–101 concentration versus time profiles (semi-log). B Two compartment model of RLS-0071 pharmacokineticsBack to article page